In a filing, Myriad Genetics, Inc revealed its President and CEO DIAZ PAUL J unloaded Company’s shares for reported $0.34 million on Oct 11 ’24. In the deal valued at $22.93 per share,15,000 shares were sold. As a result of this transaction, DIAZ PAUL J now holds 962,378 shares worth roughly $7.12 million.
Then, DIAZ PAUL J bought 15,000 shares, generating $343,950 in total proceeds.
Before that, Ancona Margaret bought 11,538 shares. Myriad Genetics, Inc shares valued at $321,019 were divested by the Officer at a price of $27.82 per share.
Guggenheim downgraded its Myriad Genetics, Inc [MYGN] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in mid March from “a Neutral” to “an Overweight”. Craig Hallum began covering MYGN with “Buy” recommendation on February 12, 2025. UBS started covering the stock on December 10, 2024. It rated MYGN as “a Neutral”.
Price Performance Review of MYGN
On Monday, Myriad Genetics, Inc [NASDAQ:MYGN] saw its stock fall -3.14% to $7.40. Over the last five days, the stock has lost -7.50%. Myriad Genetics, Inc shares have fallen nearly -46.02% since the year began. Nevertheless, the stocks have fallen -60.30% over the past one year. While a 52-week high of $29.30 was reached on 02/19/25, a 52-week low of $7.35 was recorded on 04/21/25. SMA at 50 days reached $10.37, while 200 days put it at $18.49.
Levels Of Support And Resistance For MYGN Stock
The 24-hour chart illustrates a support level at 7.28, which if violated will result in even more drops to 7.16. On the upside, there is a resistance level at 7.53. A further resistance level may holdings at 7.66. The Relative Strength Index (RSI) on the 14-day chart is 26.50, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.45%. Stochastics %K at 13.76% indicates the stock is a buying.
How much short interest is there in Myriad Genetics, Inc?
A steep rise in short interest was recorded in Myriad Genetics, Inc stocks on 2025-03-31, growing by 0.46 million shares to a total of 5.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 4.91 million shares. There was a rise of 8.51%, which implies that there is a positive sentiment for the stock.
